Rhythm Pharmaceuticals, Inc. ( RYTM) - Stock Earnings
RYTM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
RYTM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -47.5 million USD | 57.3 million USD |
| 2026Q1 | -55.6 million USD | 60.1 million USD |
| 2026Q2 | -49.3 million USD | 71.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
RYTM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -184.7 million USD | 77.4 million USD |
| 2024 | -260.6 million USD | 130.1 million USD |
| 2025 | -196.5 million USD | 189.8 million USD |
| 2026 Est. | — | — |
RYTM
Price: $86.73
52 week price:
Earnings Per Share: -3.12 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 483700
Ebitda: -8.2 millionMarket Capitalization: 6.2 billion